REQUEST A DEMO
Total
USD $0.00
Search more companies

Astrazeneca Korea Ltd. (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Astrazeneca Korea Ltd. Profile Updated: October 23, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

AstraZeneca Korea Ltd. is a pharmaceutical company located in Seoul, South Korea. The company is dedicated to transforming the future of healthcare through the power of science. They focus on creating innovative medicines and improving access to them, with the goal of benefiting patients, healthcare systems, and societies globally. AstraZeneca Korea Ltd. operates in the fields of oncology, biopharmaceuticals, and rare diseases. They are committed to sustainability and have a strategy that prioritizes access to healthcare, environmental protection, and ethics and transparency. The company values operating in a way that recognizes the interconnection between business growth, societal needs, and environmental limitations. AstraZeneca Korea Ltd. aims to deliver life-changing medicines and enhance the lives of people with diseases and illnesses. They prioritize the healthcare experience and outcomes that matter most to patients. The company is dedicated to being a great place to work, where employees can make a difference and reach their full potential. They also prioritize partnerships and collaboration to drive positive change and outcomes in the healthcare ecosystem.

Headquarters
21th Floor, 517, Yeongdong-daero Gangnam-gu Seoul
Seoul; Seoul;

Contact Details: Purchase the Astrazeneca Korea Ltd. report to view the information.

Website: http://www.astrazeneca.com

Basic Information
Total Employees:
Purchase the Astrazeneca Korea Ltd. report to view the information.
Outstanding Shares:
Purchase the Astrazeneca Korea Ltd. report to view the information.
Registered Capital:
Purchase the Astrazeneca Korea Ltd. report to view the information.
Incorporation Date:
May 04, 1992
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Astrazeneca Korea Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-6.14%
Total operating revenue
-6.14%
Operating profit (EBIT)
16.63%
EBITDA
16.57%
Net Profit (Loss) for the Period
33.23%
Total assets
11.05%
Total equity
11.98%
Operating Profit Margin (ROS)
0.96%
Net Profit Margin
1.11%
Return on Equity (ROE)
1.71%
Debt to Equity Ratio
-0.31%
Quick Ratio
0.03%
Cash Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?